Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease
Clinical trial NCT00770601 · TERMINATED
Trial details
- NCT number
- NCT00770601
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-26
- Primary completion
- 2011-02-17
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.